Literature DB >> 2844457

CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.

C Young1, T Lehner, C G Barnes.   

Abstract

The finding of part of the Herpes simplex virus type 1 (HSV1) genome in peripheral blood leucocytes of some patients with Behcet's disease (BD) led to investigations of T cell responses to HSV1 in this disease. A significantly impaired uptake of 3H-thymidine by CD4 cells was found in BD, as compared with healthy HSV1 sero-positive subjects. The impaired cellular response appeared to be specific to HSV1, as neither cytomegalovirus nor varicella-zoster virus showed depressed CD4 cell responses in BD. A similar impairment of CD4 cell responses to HSV1 was found in patients with recurrent herpetic infections, known to be caused by latent HSV1 infections. However, in rheumatoid arthritis which was selected as an unrelated autoimmune disease. 3H-thymidine uptake by CD4 cells stimulated with HSV1 was enhanced. CD8 cells showed generally rather a low uptake of 3H-thymidine, nevertheless, the values in BD and recurrent herpetic infection were again lower than those in sero-positive controls or rheumatoid arthritis. The results are consistent with the hypothesis that HSV1 might be involved in the immunopathogenesis of BD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844457      PMCID: PMC1541471     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Lymphocyte interferon production and transformation after Herpes simplex infections in humans.

Authors:  L E Rasmussen; G W Jordan; D A Stevens; T C Merigan
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

2.  Recovery of herpes-simplex virus from human trigeminal ganglions.

Authors:  J R Baringer; P Swoveland
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

3.  Maintenance of latent herpetic infection: an apparent role for anti-viral IgG.

Authors:  J G Stevens; M L Cook
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

4.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

5.  Sequential changes in T and B lymphocyte responses to Herpes simplex virus in man.

Authors:  E J Shillitoe; J M Wilton; T Lehner
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

6.  Circulating immune complexes in active Behçet's disease.

Authors:  R C Gupta; J D O'Duffy; F C McDuffie; M Meurer; R E Jordon
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

8.  Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells.

Authors:  M A Pellegrino; S Ferrone; A N Theofilopoulos
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Cell-mediated immunity in Herpesvirus hominis infections.

Authors:  J M Wilton; L Ivanyi; T Lehner
Journal:  Br Med J       Date:  1972-03-18

10.  Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.

Authors:  E J Shillitoe; J M Wilton; T Lehner
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

View more
  13 in total

Review 1.  Behçet's disease.

Authors:  T Inoue; K Satake
Journal:  Gastroenterol Jpn       Date:  1991-10

2.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

3.  Antibodies to herpes simplex virus in patients with Behçet's disease.

Authors:  M Hamza; M Elleuch; A Slim; K Hamzaoui; K Ayed
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

4.  Cytotoxic T cells against herpes simplex virus in Behçet's disease.

Authors:  K Hamzaoui; A Kahan; K Ayed; M Hamza
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease.

Authors:  S Lee; D Bang; Y H Cho; E S Lee; S Sohn
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

6.  Neuro-Behçet: clinical features and MRI correlates.

Authors:  F Federico; M G Damiani; R De Blasi; M De Mari; P Lamberti; P Lattanzi; A Carella
Journal:  Ital J Neurol Sci       Date:  1993-01

7.  Gene expression of tumour necrosis factor-alpha (TNF-alpha) and heat-shock protein (HSP) 70 in patients with Behçet's disease.

Authors:  Y Yamakawa; Y Sugita; Y Takahashi; T Yamakawa; S Tanaka; S Nakamura; J Fukushima; S Kawamoto; S Ohno; K Okuda
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors:  I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

9.  Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

Authors:  I Kötter; A K Eckstein; N Stübiger; M Zierhut
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

10.  Decreased serum level of antibody against human cytomegalovirus in patients with Behçet's disease.

Authors:  Eun Bong Lee; Ye Jin Kwon; Ki Chul Shin; Yeong Wook Song; Chung-Gyu Park; Eung-Soo Hwang; Chang-Yong Cha
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.